Clinical Features of Refractory Ascites in Outpatients

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.72, n.7, p.405-410, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: To present the clinical features and outcomes of outpatients who suffer from refractory ascites. METHODS: This prospective observational study consecutively enrolled patients with cirrhotic ascites who submitted to a clinical evaluation, a sodium restriction diet, biochemical blood tests, 24 hour urine tests and an ascitic fluid analysis. All patients received a multidisciplinary evaluation and diuretic treatment. Patients who did not respond to the diuretic treatment were controlled by therapeutic serial paracentesis, and a transjugular intrahepatic portosystemic shunt was indicated for patients who required therapeutic serial paracentesis up to twice a month. RESULTS: The most common etiology of cirrhosis in both groups was alcoholism [49 refractory (R) and 11 non-refractory ascites (NR)]. The majority of patients in the refractory group had Child-Pugh class B cirrhosis (p=0.034). The nutritional assessment showed protein-energy malnutrition in 81.6% of the patients in the R group and 35.5% of the patients in the NR group, while hepatic encephalopathy, hernia, spontaneous bacterial peritonitis, upper digestive hemorrhage and type 2 hepatorenal syndrome were present in 51%, 44.9%, 38.8%, 38.8% and 26.5% of the patients in the R group and 9.1%, 18.2%, 0%, 0% and 0% of the patients in the NR group, respectively (p=0.016, p=0.173, p=0.012, p=0.012, and p=0.100, respectively). Mortality occurred in 28.6% of the patients in the R group and in 9.1% of the patients in the NR group (p=0.262). CONCLUSION: Patients with refractory ascites were malnourished, suffered from hernias, had a high prevalence of complications and had a high postoperative death frequency, which was mostly due to infectious processes.
Palavras-chave
Ascites, Hepatic Encephalopathy, Liver, Liver Cirrhosis, Outpatients
Referências
  1. Albillos A, 2005, J HEPATOL, V43, P990, DOI 10.1016/j.jhep.2005.06.005
  2. Altamirano J, 2012, CLIN GASTROENTEROL H, V10, P65, DOI 10.1016/j.cgh.2011.09.011
  3. Andraus W, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0052-y
  4. Angeli P, 2010, GUT, V59, P98, DOI 10.1136/gut.2008.176495
  5. ARROYO V, 1981, ANN INTERN MED, V94, P198
  6. Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122
  7. ARROYO V, 1986, AM J MED, V81, P104, DOI 10.1016/0002-9343(86)90912-5
  8. ARROYO V, 1983, EUR J CLIN INVEST, V13, P271, DOI 10.1111/j.1365-2362.1983.tb00100.x
  9. Biggins SW, 2005, HEPATOLOGY, V41, P32, DOI 10.1002/hep.20517
  10. Bittencourt Paulo Lisboa, 2010, Arq. Gastroenterol., V47, P202, DOI 10.1590/S0004-28032010000200017
  11. BLACKBURN GL, 1979, MED CLIN N AM, V63, P1103
  12. Boyer TD, 2005, HEPATOLOGY, V41, P386, DOI 10.1002/hep.20559
  13. D'Amico G, 2005, GASTROENTEROLOGY, V129, P1282, DOI 10.1053/j.gastro.2005.07.031
  14. Deltenre P, 2005, LIVER INT, V25, P349, DOI 10.1111/j.1478-3231.2005.01095.x
  15. Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015
  16. Fasolato S, 2007, HEPATOLOGY, V45, P223, DOI 10.1002/hep.21443
  17. Gaba R C, 2015, Clin Radiol, V70, pe51, DOI 10.1016/j.crad.2015.02.002
  18. Garcia-Tsao G, 2006, NAT CLIN PRACT GASTR, V3, P380, DOI 10.1038/ncpgasthep0523
  19. Gines A, 1996, GASTROENTEROLOGY, V111, P1002, DOI 10.1016/S0016-5085(96)70068-9
  20. GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124
  21. Gines P, 2010, J HEPATOL, V53, P397
  22. Guevara M, 2010, LIVER INT, V30, P1137, DOI 10.1111/j.1478-3231.2010.02293.x
  23. Heuman DM, 2004, HEPATOLOGY, V40, P802, DOI 10.1002/hep.20405
  24. Juakiem W, 2014, CLIN LIVER DIS, V18, P179, DOI 10.1016/j.cld.2013.09.004
  25. Jung HS, 2009, J VASC INTERV RADIOL, V20, P180, DOI 10.1016/j.jvir.2008.11.005
  26. Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209
  27. LOGUERCIO C, 1990, BRIT J CLIN PRACT, V44, P98
  28. Londono MC, 2007, GUT, V56, P1283, DOI 10.1136/gut.2006.102764
  29. Marsman HA, 2007, SURGERY, V142, P372, DOI 10.1016/j.surg.2007.05.006
  30. MCCULLOUGH AJ, 1992, GASTROENTEROLOGY, V102, P1325
  31. MERLI M, 1994, NUTRITION, V10, P566
  32. Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315
  33. MULLER MJ, 1995, J HEPATOL, V23, P31
  34. POCKROS PJ, 1986, GASTROENTEROLOGY, V90, P1827
  35. Rossle M, 2000, NEW ENGL J MED, V342, P1701, DOI 10.1056/NEJM200006083422303
  36. RUNYON BA, 1994, NEW ENGL J MED, V330, P337, DOI 10.1056/NEJM199402033300508
  37. Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359
  38. Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853
  39. SALERNO F, 1987, J HEPATOL, V5, P102, DOI 10.1016/S0168-8278(87)80067-3
  40. Salerno F, 2004, HEPATOLOGY, V40, P629, DOI 10.1002/hep.20364
  41. Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789
  42. Salerno F, 2010, LIVER INT, V30, P937, DOI 10.1111/j.1478-3231.2010.02272.x
  43. Sam J, 2009, LIVER INT, V29, P1396, DOI 10.1111/j.1478-3231.2009.02077.x
  44. Santos J, 2003, J HEPATOL, V39, P187, DOI 10.1016/S0168-8278(03)00188-0
  45. Sanyal AJ, 2003, GASTROENTEROLOGY, V124, P634, DOI 10.1053/gast.2003.50088
  46. SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532
  47. Senousy BE, 2009, WORLD J GASTROENTERO, V15, P67, DOI 10.3748/wjg.15.67
  48. Sorrentino P, 2012, J GASTROEN HEPATOL, V27, P813, DOI 10.1111/j.1440-1746.2011.07043.x
  49. Teiusanu Adriana, 2012, Maedica (Buchar), V7, P284